4
Changes in Ownership
GENELUX Corp Filed Acc 0001415889-24-016101
VP, Clinical Trial Operations bought 2,500 shares
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yu Yong VP, Clinical Trial Operations | 2024-05-29 | Purchase | +2,500 | 2,500 | D | ||
| Derivatives | |||||||
| Yu Yong VP, Clinical Trial Operations | 2024-05-29 | Purchase · Common Stock Warrant (Right to Buy) | +2,500 | 2,500 | D | ||
| Open-market purchases · 2,500 sh | |||||||
Loading xslF345X05/form4-06072024_090610.xml…